MTCH2

Mitochondrial carrier homolog 2 · Q9Y6C9 · MTCH2 on Sugi Atlas →

0 patent compounds predicted against MTCH2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to MTCH2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve) PHASE3WITHDRAWN
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease PHASE3COMPLETED
Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans PHASE2RECRUITING
Doxecitin and Doxribthymine in Adult Subjects With Thymidine Kinase 2 (TK2) Deficiency PHASE2RECRUITING
A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy PHASE2ACTIVE_NOT_RECRUITING
Identification of New Candidate Genes in Patients With Mitochondrial Disease by High Resolution Chromosome Analysis on DNA Chip nanCOMPLETED
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) nanRECRUITING
The Natural History of Mitochondrial Diseases nanRECRUITING
Mitochondrial Dysfunction in Phelan-McDermid Syndrome nanCOMPLETED
Tissue Sample Study for Mitochondrial Disorders nanENROLLING_BY_INVITATION
Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine nanCOMPLETED
Survey on Supplement Use in Mitochondrial Disease nanCOMPLETED
Natural History Study - Mitochondrial Disease nanRECRUITING
MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial Diseases nanRECRUITING
Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Mitochondrial DNA in Peripheral Blood Leukocytes nanNOT_YET_RECRUITING
Gastrointestinal Dysfunction in Children Affected With Mitochondrial Disorders nanCOMPLETED
Identification of Large-Scale Mutations of POLG Gene by QMPSF in Patients With Mitochondrial DNA Instability. nanUNKNOWN
Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC)) nanCOMPLETED
Nutritional Assessment in Mitochondrial Cytopathy nanCOMPLETED
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants nanRECRUITING
Systemic Biomarkers of Brain Injury From Hyperammonemia nanRECRUITING
Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity nanRECRUITING
Calf Muscle Strength in Mitochondrial Diseases nanCOMPLETED
Rhizomelic Chondrodysplasia Punctata Registry nanRECRUITING
Natural History Study of Mitochondrial Myopathy nanRECRUITING
Longitudinal Study of Mitochondrial Hepatopathies nanSUSPENDED
Genomic of CONgenital Sideroblastic Anemias nanRECRUITING
Diagnostic Odyssey Survey 2 nanCOMPLETED
Mitochondrial Disease-associated ImmunoDeficiencies nanRECRUITING
Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a MTCH2 binder may also engage these)

ProteinNameSimilarity
Q5R5M0 1.000 Q5R5M0 →
Q791V5 0.998 Q791V5 →
Q9N285 0.997 Q9N285 →
Q791T5 0.962 Q791T5 →
Q9NZJ7 0.960 Q9NZJ7 →
Q66H23 0.939 Q66H23 →
Q920G8 0.932 Q920G8 →
Q7T292 0.932 Q7T292 →
Q9NYZ2 0.930 Q9NYZ2 →
Q9FI43 0.930 Q9FI43 →
Q287T7 0.924 Q287T7 →
Q6P4H8 0.922 Q6P4H8 →
Q7SXW0 0.921 Q7SXW0 →
Q9LY28 0.921 Q9LY28 →
Q923S8 0.920 Q923S8 →
Q5F477 0.919 Q5F477 →
Q0VCK9 0.919 Q0VCK9 →
Q2HJF8 0.919 Q2HJF8 →
Q9DB41 0.919 Q9DB41 →
Q99KU0 0.919 Q99KU0 →
Q6PGY3 0.918 Q6PGY3 →
O70579 0.918 O70579 →
Q9LV81 0.918 Q9LV81 →
Q5R9K4 0.917 Q5R9K4 →
Q4R4U1 0.917 Q4R4U1 →
Q5R5F8 0.917 Q5R5F8 →
A5A6S6 0.916 A5A6S6 →
Q9NVE7 0.916 Q9NVE7 →
D3ZXD8 0.915 D3ZXD8 →
Q6PC62 0.915 Q6PC62 →